latest content

featured content

filter by categories

jumping the hurdles to value-based care

by
August 16, 2017

The transition from fee-for-service to value-based healthcare, where payers compensate providers based on the patient’s quality outcomes, is still moving slowly. What are the major obstacles standing in the way of providers taking on more risk?

 

Verscend president and CEO Dr. Emad Rizk recently sat down with Healthcare Informatics to talk about why the lack of data sharing between payers and providers is impeding value-based care’s momentum. In the interview, he discusses:

  • What true value-based care actually looks like
  • Why it’s “mind-boggling” that payers and providers haven’t yet integrated claims data with clinical data
  • Why providers are reluctant to take on risk
  • How regional health plans and healthcare systems can coordinate with each other in a practical way
  • Why interoperability across electronic medical record (EMR) systems is critical

To read Dr. Rizk’s insights, view the full article in Healthcare Informatics.

read the article

Dr. Emad Rizk joined Verscend in August 2016 and serves as president and CEO. A seasoned and renowned healthcare industry senior executive, Dr. Rizk brings to this role more than 25 years of experience working closely with payers, providers, and government entities. Most recently, he served as CEO of Accretive Health and was also a member of its board of directors. Prior to Accretive Health, Dr. Rizk was president of McKesson Health Solutions, a business that provides clinical and financial solutions to healthcare payers. Dr. Rizk’s work has been published frequently in journals and books, and he has been widely recognized in the healthcare Industry. Modern Healthcare has named Dr. Rizk numerous times as one of the “50 Most Influential Physician Executives in the United States,” and the “Top 100 Most Powerful People in Healthcare.” Managed Healthcare Executive also named him to its “Top 25 Leaders in Disease Management.”

don’t miss an update

leave a comment below: